Modeling the Effect of Spatial Structure on Solid Tumor Evolution and Circulating Tumor DNA Composition
Circulating tumor DNA (ctDNA) monitoring, while sufficiently advanced to reflect tumor evolution in real time and inform cancer diagnosis, treatment, and prognosis, mainly relies on DNA that originates from cell death via apoptosis or necrosis. In solid tumors, chemotherapy and immune infiltration c...
Main Authors: | Thomas Rachman, David Bartlett, William LaFramboise, Patrick Wagner, Russell Schwartz, Oana Carja |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/5/844 |
Similar Items
-
Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
by: Lemei Zhu, et al.
Published: (2023-08-01) -
Utilization of Circulating Tumor Cells in the Management of Solid Tumors
by: Peter C. Kurniali, et al.
Published: (2023-04-01) -
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
by: Steven P. Rowe, et al.
Published: (2018-10-01) -
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
by: Estela Sánchez-Herrero, et al.
Published: (2022-07-01) -
Circulating tumor DNA – A potential aid in the management of chordomas
by: Stephen C. Frederico, et al.
Published: (2022-10-01)